Predictors of sudden cardiac death and the impact of coronary artery bypass grafting on their development
Abstract
Sudden Cardiac Death (SCD) is one of the most severe and life-threatening manifestations of cardiovascular diseases and is among the leading causes of mortality worldwide. The primary pathogenic factors contributing to the development of this condition include ischemic heart disease (IHD), ventricular arrhythmias, reduced left ventricular ejection fraction (LVEF), and the formation of scar tissue in the myocardium.
The mechanism underlying SCD is complex, involving a combination of myocardial ischemia, electrical instability, and morphological changes, all of which contribute to the onset of malignant arrhythmias.
Coronary artery bypass grafting (CABG) is an effective revascularization technique in patients with ischemic heart disease. It not only alleviates symptoms but also significantly improves long-term prognosis by enhancing cardiac function.
Studies have shown that CABG, particularly in patients with reduced LVEF, decreases overall mortality and the risk of developing SCD.
In conclusion, CABG plays an important role in the prevention of SCD, but it is not a standalone solution. A thorough analysis of the underlying risk factors, early identification of high-risk patients, and the development of individualized, comprehensive preventive and therapeutic strategies represent the most effective approach in reducing SCD incidence.
About the Authors
List of references
ESC Scientific Document Group. [2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. G Ital Cardiol (Rome). 2023;24(3 Suppl 1):e1–e132. Russian.
Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043–52.
Stecker EC, Reinier K, Marijon E, Narayanan K, Teodorescu C, Uy-Evanado A, Gunson K, Jui J, Chugh SS. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol. 2014;7(2):212–7.
Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital coronary heart disease mortality in Sweden (1991–2006). Circulation. 2011;123(1):46–52.
Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death, 1950 to 1999: the Framingham Heart Study. Circulation. 2004;110(5):522–7.
Risgaard B, Winkel BG, Jabbari R, Baer ER, Ingemann-Hansen O, Thomsen JL, et al. Burden of sudden cardiac death in persons aged 1 to 49 years: a nationwide study in Denmark. Circ Arrhythm Electrophysiol. 2014;7(2):205–11.
Hayashi M, Shimizu W, Albert CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res. 2015;116(12):1887–906.
Katritsis DG, Gersh BJ, Camm AJ. Sudden cardiac death: a clinical perspective. Arrhythm Electrophysiol Rev. 2016;5(3):177–82.
Tiwari L, Lockey A, Böttiger BW, Rott N, Hoover AV, Chakra Rao S, et al. Over 302 million reached and over 2,200,000 trained in CPR worldwide: the 2021 ILCOR World Restart a Heart initiative. Resusc Plus. 2023;14:100375.
Lynge TH, Risgaard B, Banner J, Nielsen JL, Jespersen T, Stampe NK, et al. Nationwide burden of sudden cardiac death: a study of 54,028 deaths in Denmark. Heart Rhythm. 2021;18(10):1657–65.
Ågesen FN, Lynge TH, Blanche P, Banner J, Prescott E, Jabbari R, Tfelt-Hansen J. Temporal trends and gender differences in sudden cardiac death in the Copenhagen Heart Study. Heart. 2021;107(16):1303–9.
Wong CX, Brown A, Lau DH, Chugh SS, Albert CM, Kalman JM, Sanders P. Epidemiology of sudden cardiac death: global and regional perspectives. Heart Lung Circ. 2019;28(1):6–14.
Paul H, Dimitrios L. Ventricular arrhythmias and sudden cardiac death. BJA Educ. 2016;16(7):221–9. https://doi.org/10.1093/bjaed/mkv056.
Thomas DE, Jex N, Thornley AR. Ventricular arrhythmias in acute coronary syndromes—mechanisms and management. Cont Cardiol Educ. 2017;3(1). https://doi.org/10.1002/cce2.51.
Centurión OA. Abolition of ventricular tachycardia by revascularization: when blood flow is all you need to terminate a recurrent ischemic ventricular arrhythmia. M J Cardiol. 2016;1(2):006.
Bayes ABDL, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117:151–9.
Stern S, Banai S, Keren A, Tzivoni D. Ventricular ectopic activity during myocardial ischemic episodes in ambulatory patients. Am J Cardiol. 1990;65(7):412–6.
Centurión OA. Abolition of ventricular tachycardia by revascularization: when blood flow is all you need to terminate a recurrent ischemic ventricular arrhythmia. M J Cardiol. 2016;1(2):006.
Robert J. Myerburg, Jeffrey J Goldberger. Cardiac Arrest and Sudden Cardiac Death. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, Eleventh Edition 2019; 807-844.
Meiso Hayashi, MD, Wataru Shimizu, MD, PhD at. all. The Spectrum of Epidemiology Underlying Sudden Cardiac Death Circ Res. 2015 June 5; 116(12): 1887–1906. https://doi.org/10.1161/CIRCRESAHA.116.304521.
Carson P, Wertheimer J, Miller A, O‘Connor CM, Pina IL, Selzman C, et al. The STICH trial (Surgical treatment for ischemic heart failure): Mode-of-death results. JACC Heart Fail 2013;1:400.
Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation. 1983 Nov;68(5):939-50.
Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, et al. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions 50% versus >50% (from the CREDO-kyoto PCI/CABG registry cohort-2). Am J Cardiol 2014;114:988-96 ).
Suzinova A/, et all The effect of myocardial revascularization on malignant ventricular arrhythmias in coronary artery disease. Bratisl Lek Listy 2009;110 (4) 61. Waks et al Global Electric Heterogeneity Risk Score for Prediction of Sudden ).
Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death 2016).
Bigger JT Jr, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB, Steinman RC, Estes NA 3rd. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation. 1999 Mar 23;99(11):1416-21. https://doi.org/10.1161/01.cir.99.11.1416.PMID:10086963.
Hohnloser SH, Kuck KH, Dorian P va boshqalar. Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction. New England Journal of Medicine, 2004;351:2481-2488.).
Ventricular arrhythmia following successful myocardial revascularization: incidence, predictors and prevention», Kaul T.K. va boshq., Eur J Cardiothorac Surg, 1998)
Copyright (c) 2025 А.Ш. Расулов, Р.Д. Курбанов, Г.У. Муллабаева, Э.Я. Турсунов, А.Г. Кеворков, К.Ш. Сайфиддин Ходжи (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.